Evaluation
*
*
Please use the scale: 1=Very poor, 2=Poor, 3=Neutral, 4=Good, 5=Excellent
12345
Overall evaluation
Content
Usefulness
Quality
*
Please use the scale: 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, 5= Strongly agree
12345
Discuss novel diagnostic strategies, updated guidelines, and the principles of precision medicine for the cystic fibrosis patient.
Analyze the improved disease progression in cystic fibrosis patients who have received CFTR modulation therapy.
Review the most current and emerging clinical trial data for CFTR modulation, as well as combination therapies, in the patient with cystic fibrosis.
Optimize your strategies to manage and monitor CFTR modulator‐treated cystic fibrosis patients.
*
*
Please use the scale: 1=NOT at all confident, 2=Not very confident, 3=Somewhat confident, 4=Confident, 5=Very confident
12345
Effectively diagnose patients with CF?
Develop treatment plans to optimize patients outcomes?
*
*
*
Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable for me
12345N/A
Recognize improved disease progression in patients who have received CFTR modulation therapy.
Develop optimal treatment strategies to effectively manage patients with CF.
Apply knowledge of current clinical trial data of CFTR modulation therapy into individualized patient treatment plans.
Review updated guidelines and diagnostic strategies to effectively implement them into practice.